Arimistane
Shop Arimistane on KimeraChems · code GUIDE (10% off)Definition
Arimistane is a steroidal compound researched primarily for its potential aromatase-inhibiting activity. In research contexts, it is explored for its ability to reduce the enzymatic conversion of androgens into estrogens, which may alter the estrogen-to-androgen balance depending on baseline endocrine status and study design. Arimistane is often discussed in supplementation contexts as a nonprescription aromatase inhibitor. However, robust human clinical data are limited, so many claims are based on mechanistic rationale and preclinical-style interpretation.
Available Formats
- Dry-fill capsules (commonly 25 mg per capsule, 60-count / 1.5 g total)
- 30 mL liquid solution (25 mg per mL / 750 mg total)
- Powder (commonly available in 1-gram and 5-gram bulk options)
Mechanism of Action
Research discussions suggest Arimistane may: Because aromatase activity varies substantially between experimental models, observed outcomes may be highly context-dependent.
- Reduce aromatase-enzyme activity
- Decrease the conversion of testosterone into estradiol in responsive models
- Shift the androgen-to-estrogen balance depending on baseline aromatization rate
- Indirectly influence luteinizing hormone (LH) and follicle-stimulating hormone (FSH) dynamics through altered estrogen feedback
- Affect estrogen-sensitive tissues and signaling pathways by reducing estrogen availability
Areas of Investigation
Arimistane is commonly discussed or explored in
- Estrogen-modulation research designs
- Hormone-balance studies in which aromatization is a variable
- Androgen-to-estrogen ratio manipulation models
- Body-composition-oriented endocrine research paradigms
- Comparative studies involving other aromatase-inhibiting compounds
- Protocol-support research in which estrogen control is a dependent variable
Safety Profile
Reported observations and conservative monitoring considerations include
- Low-estrogen-related effects in over-suppressed models, including low mood, reduced libido, joint discomfort, and sleep disruption
- Headache or gastrointestinal discomfort in some subjects
- Changes in lipid markers during extended aromatase-inhibition paradigms
- Potential rebound effects after discontinuation, depending on study structure and baseline endocrine conditions
Interaction Notes
Arimistane is often discussed in research alongside compounds or variables that influence aromatization, androgen signaling, or hormonal feedback
For educational purposes only. Not for human consumption.